Activation of coagulation, anti-coagulation, fibrinolysis and the complement system in patients with urticaria

Asian Pacific Journal of Allergy and Immunology

Volumn 31, Issue 1, 2013, Pages 43-50

  Zhu, Huilan ^a   Liang, Bihua ^a   Li, Runxiang ^a   Li, Jiayan ^a   Lin, Luyang ^a   Ma, Shaoyin ^a   Wang, Junfeng ^b  

^a GUANGZHOU INSTITUTE OF DERMATOLOGY   (China)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Anticoagulation; Coagulation; Complement; Fibrinolysis; Urticaria

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 9; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C5A; D DIMER; HIGH MOLECULAR WEIGHT KININOGEN; PROTHROMBIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN ANTITHROMBIN COMPLEX; THROMBOMODULIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR;

ADOLESCENT; ADULT; AGED; ANTICOAGULATION; ARTICLE; CHILD; CLINICAL ARTICLE; COMPLEMENT SYSTEM; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; HUMAN; MALE; NEPHELOMETRY; PATHOGENESIS; URTICARIA;

ADOLESCENT; ADULT; AGED; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; CHILD; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; FEMALE; FIBRINOLYSIS; HUMANS; MALE; MIDDLE AGED; URTICARIA; YOUNG ADULT;

EID: 84878079265     PISSN: 0125877X     EISSN: 22288694     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kulthanan K, Jiamton S, Thumpimukvatana N, Pinkaew S. Chronic idiopathic urticaria: prevalence and clinical course. J Dermatol. 2007;34:294-301.
2. Hennino A, Berard F, Guillot I, Saad N, Rozières A, Nicolas JF. Pathophysiology of urticaria. Clin Rev Allergy Immunol. 2006;30:3-11.
3. Zuberbier T, Bindslev-jensen C, Canonica W, Grattan CE, Greaves MW, Henz BM, et al. EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy. 2006;61:316-20.
4. Asero R, Tedeschi A, Riboldi P, Cugno M. Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum. J Allergy Clin Immunol. 2006;117:1113-7.
5. Asero R, Tedeschi A, Coppola R, Griffini S, Paparella P, Riboldi P, et al. Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria. J Allergy Clinical Immunol. 2007;119:705-10.
6. Parslew R, Pryce D, Ashworth J, Friedmann PS. Warfarin treatment of chronic idiopathic urticaria and angio-oedema. Clin Exp Allergy. 2000,30:1161-5.
7. Chua SL, Gibbs S. Chronic urticaria responding to subcutaneous heparin sodium. Br J Dermatol. 2005;153:216-7.
8. Asero R, Tedeschi A, Cugno M. Heparin and tranexamic Acid therapy may be effective in treatment-resistant chronic urticaria with elevated d-dimer: a pilot study. Int Arch Allergy Immunol. 2010;152:384-9.
9. Ota S, Wada H, Abe Y, Yamada E, Sakaguchi A, Nishioka J, et al. Elevated levels of prothrombin fragment 1+2 indicate high risk of thrombosis. Clin Appl Thromb Hemost. 2008;14:279 -85.
10. Asero R, Tedeschi A, Riboldi P, Griffini S, Bonanni E, Cugno M. Severe chronic urticaria is associated with elevated plasma levels of D-dimer. Allergy. 2008;63:176-80.
11. Fujii K, Usuki A, Kan-No Y, Ohgou N. Elevation of circulating thrombin-antithrombin III complex and fibrin degradation products in urticaria: a laboratory finding unrelated to intravascular coagulopathy. J Dermatol. 2008;35:308-10.
12. Kido H, Fukusen N, Katunuma N, Morita T, Iwanaga S. Tryptase from rat mast cells converts bovine prothrombin to thrombin. Biochem Biophys Res Commun. 1985;132:613-9.
13. Schaeffer RC, Gong F, Bitrick MS, Smith TL. Thrombin and bradykinin initiate discrete endothelial solute permeability mechanisms. Am J Physiol. 1993 Jun; 264(6 Pt 2): H1798-809.
14. Cugno M, Marzano AV, Tedeschi A, Fanoni D, Venegoni L, Asero R. Expression of Tissue Factor by Eosinophils in Patients with Chronic Urticaria. Int Arch Allergy Immunol. 2009;148:170-4.
15. Kasperska-Zajac A, Brzoza Z. Increased D-dimer concentration in plasma of patients with severe acute urticaria. Br J Dermatol. 2009;161:1409-10.
16. Kasperska-Zajac A, Brzoza Z, Rogala B. Blood urokinase plasminogen activator system in chronic urticaria. Arch Dermatol Res. 2007;298:409-11.
17. Huber-Lang M, Sarma JV, Zetoune FS, Rittirsch D, Neff TA, McGuire SR, et al. Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med. 2006;12:682-7.
18. Kikuchi Y, Kaplan AP. A role for C5a in augmenting IgGdependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol. 2002;109:114 -8.
19. Asero R, Riboldi P, Tedeschi A,Cugno M, Meroni P. Chronic urticaria: a disease at a crossroad between autoimmunity and coagulation. Autoimmun Rev. 2007;7:71-6.
20. Valent P, Baghestanian M, Bankl H C, Sillaber C, Sperr WR, Wojta J. New aspects in thrombosis research: possible role of mast cells as profibrinolytic and antithrombotic cells. Thromb Haemost.2002;87:786-90.